CASSIE BURT: Open Payments
NPI 1326129172 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$698 in 29 payments from 21 companies in 2025. Trend: 2023 $175 · 2024 $635 · 2025 $698
Food & beverage: $698
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $79 |
| Alexion Pharmaceuticals, Inc. | 3 | $66 |
| GlaxoSmithKline, LLC. | 2 | $50 |
| Daiichi Sankyo Inc. | 2 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $45 |
| Merck Sharp & Dohme LLC | 2 | $43 |
| Aveo Pharmaceuticals, Inc. | 1 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
Products named: ENHERTU, ULTOMIRIS, OJJAARA, Nubeqa, KEYTRUDA, FOTIVDA, NINLARO, LIBTAYO.
Industry payments across GA — which companies pay providers there.
